EE200100607A - Pharmaceutical composition in granular form and a process for its preparation - Google Patents
Pharmaceutical composition in granular form and a process for its preparationInfo
- Publication number
- EE200100607A EE200100607A EEP200100607A EEP200100607A EE200100607A EE 200100607 A EE200100607 A EE 200100607A EE P200100607 A EEP200100607 A EE P200100607A EE P200100607 A EEP200100607 A EE P200100607A EE 200100607 A EE200100607 A EE 200100607A
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- pharmaceutical composition
- granular form
- granular
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Liquid Deposition Of Substances Of Which Semiconductor Devices Are Composed (AREA)
- Glanulating (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI9900119A SI20244A (en) | 1999-05-19 | 1999-05-19 | Melt granulation |
PCT/SI2000/000013 WO2000069415A2 (en) | 1999-05-19 | 2000-05-18 | Melt granulation |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200100607A true EE200100607A (en) | 2003-02-17 |
Family
ID=20432471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200100607A EE200100607A (en) | 1999-05-19 | 2000-05-18 | Pharmaceutical composition in granular form and a process for its preparation |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1183013A2 (en) |
AU (1) | AU4969700A (en) |
BG (1) | BG106236A (en) |
CZ (1) | CZ20014133A3 (en) |
EE (1) | EE200100607A (en) |
HR (1) | HRP20010932A2 (en) |
HU (1) | HUP0201233A3 (en) |
PL (1) | PL351654A1 (en) |
RU (1) | RU2001134166A (en) |
SI (1) | SI20244A (en) |
SK (1) | SK16642001A3 (en) |
WO (1) | WO2000069415A2 (en) |
YU (1) | YU82001A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA02009587A (en) * | 2000-03-28 | 2003-05-14 | Biochemie Gmbh | Granulated particles with masked taste. |
CA2425688A1 (en) * | 2000-10-13 | 2002-05-16 | Donald J. Treacy Jr. | Extended release erythromycin derivatives |
KR100913281B1 (en) * | 2002-02-21 | 2009-08-21 | 오츠카 세이야쿠 가부시키가이샤 | Sustained Release Preparation and Process for Producing the Same |
US7943585B2 (en) | 2003-12-22 | 2011-05-17 | Sandoz, Inc. | Extended release antibiotic composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991019486A1 (en) * | 1990-06-14 | 1991-12-26 | Kalmo Enterprises, Inc. | Stable aqueous drug suspensions |
JP3265680B2 (en) * | 1992-03-12 | 2002-03-11 | 大正製薬株式会社 | Oral pharmaceutical composition |
AU5681294A (en) * | 1992-11-30 | 1994-06-22 | Kv Pharmaceutical Company | Tastemasked pharmaceutical materials |
IT1312058B1 (en) * | 1999-04-09 | 2002-04-04 | Pharmaplus S R L | METHOD FOR MICRO-ENCAPSULATION OF MEDICATIONS. |
-
1999
- 1999-05-19 SI SI9900119A patent/SI20244A/en not_active IP Right Cessation
-
2000
- 2000-05-18 CZ CZ20014133A patent/CZ20014133A3/en unknown
- 2000-05-18 PL PL00351654A patent/PL351654A1/en not_active Application Discontinuation
- 2000-05-18 RU RU2001134166/14A patent/RU2001134166A/en not_active Application Discontinuation
- 2000-05-18 HU HU0201233A patent/HUP0201233A3/en unknown
- 2000-05-18 EE EEP200100607A patent/EE200100607A/en unknown
- 2000-05-18 EP EP00931886A patent/EP1183013A2/en not_active Withdrawn
- 2000-05-18 YU YU82001A patent/YU82001A/en unknown
- 2000-05-18 WO PCT/SI2000/000013 patent/WO2000069415A2/en not_active Application Discontinuation
- 2000-05-18 SK SK1664-2001A patent/SK16642001A3/en unknown
- 2000-05-18 AU AU49697/00A patent/AU4969700A/en not_active Abandoned
-
2001
- 2001-12-18 HR HR20010932A patent/HRP20010932A2/en not_active Application Discontinuation
- 2001-12-19 BG BG106236A patent/BG106236A/en unknown
Also Published As
Publication number | Publication date |
---|---|
SK16642001A3 (en) | 2002-05-09 |
EP1183013A2 (en) | 2002-03-06 |
CZ20014133A3 (en) | 2002-03-13 |
PL351654A1 (en) | 2003-05-19 |
RU2001134166A (en) | 2003-08-27 |
YU82001A (en) | 2004-07-15 |
HRP20010932A2 (en) | 2003-04-30 |
SI20244A (en) | 2000-12-31 |
HUP0201233A2 (en) | 2002-08-28 |
AU4969700A (en) | 2000-12-05 |
WO2000069415A2 (en) | 2000-11-23 |
HUP0201233A3 (en) | 2003-10-28 |
WO2000069415A3 (en) | 2001-04-26 |
BG106236A (en) | 2002-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0302550A3 (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines and pharmaceutical compositions containing them | |
ATE280583T1 (en) | STABILIZED PHARMACEUTICAL COMPOSITION IN LYOPHILIZED FORM | |
IL149618A0 (en) | Pharmaceutical compositions comprising thiazolidinedione and process for preparation thereof | |
HUP0201936A3 (en) | Multi-component pharmaceutical dosage form | |
EE200100684A (en) | Indalyl-substituted benzenecarboxamides, process for their preparation, use and pharmaceutical compositions | |
HUP0203588A3 (en) | Analgesic pharmaceutical compositions and their use | |
PL351387A1 (en) | Pharmaceutical composition | |
IL151372A0 (en) | Cyclopropyl-fused pyrrolidine derivatives and pharmaceutical compositions containing the same | |
HK1046236A1 (en) | Rapidly dissolving dosage form and process for making same | |
HUP0200548A2 (en) | Pharmaceutical compositions and their use | |
HUP0202329A2 (en) | Pharmaceutical composition in unit form containing acetylsalycilic acid and clopidogrel hydrogenosulphate | |
HUP0302130A3 (en) | Combination pharmaceutical compositions and process for their preparation | |
CZ2006533A3 (en) | Amorphous ritonavir, methods for its preparation, its use, and a pharmaceutical composition comprising it | |
HUP0302099A3 (en) | Azythromycin in the form of a monohydrate, process for its preparation and pharmaceutical composition containing in the monohydrate form | |
EE200000657A (en) | Azoles, process for their preparation, use as a pharmaceutical and pharmaceutical composition | |
GB9918885D0 (en) | Pharmaceutical formulations in hydroxypropymethycellulose capsules | |
FI4488U1 (en) | Pharmaceutical composition | |
EE200100607A (en) | Pharmaceutical composition in granular form and a process for its preparation | |
HUP0203383A3 (en) | Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof | |
HUP0201443A2 (en) | 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them | |
IL148164A0 (en) | Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation | |
AU8395901A (en) | Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field | |
HUP9902559D0 (en) | Pharmaceutical composition and process for producing it | |
FI982793A0 (en) | Pharmaceutical composition and process for its preparation | |
EP1235806A4 (en) | Novel 5-pyrimidinecarboxamide derivatives and the pharmaceutical compositions containing said derivatives |